Respiratory sEMG in dyspneic children before and after treatment with Salbutamol.

Respiratory sEMG in dyspneic children before and after treatment with Salbutamol. - A Dyspnea Sensor for children

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52077

Enrollment

Registered

2022-03-08

Start date

2022-04-06

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Dyspnea

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: a) • Diagnosed or suspected with Asthma • Having a reversibility test scheduled • Age 5-10 yrs b) • Acute Dyspnea • Treated with Salbutamol at the ER Unit • Age 3-10 yrs

Exclusion criteria

Exclusion criteria: • Congenital diseases that can cause dyspnea, i.e. severe congenital heart defects or Cystic Fybrosis • History of Herniated Diaphragm • Allergy of EMG-electrodes • Ex-prematures with a gestational age at birth

Design outcomes

Primary

Measure	Time frame
Primary endpoint is the difference between EMG-measured muscle activity of the diaphragm before and after Salbutamol administration.	—

Secondary

Measure	Time frame
Secondary endpoints are: • Correlation between the change in EMG-measured diaphragmatic muscle activity and the change in CAS values in acute dyspnoeic children. • Correlation between the change in EMG-measured diaphragmatic muscle activity and the change in Borg values in acute dyspnoeic children. • Correlation between the change in EMG-measured diaphragmatic muscle activity and the change in FEV1 values in non-acute dyspnoeic children.	—

Measure

Time frame

Secondary endpoints are: • Correlation between the change in EMG-measured diaphragmatic muscle activity and the change in CAS values in acute dyspnoeic children. • Correlation between the change in EMG-measured diaphragmatic muscle activity and the change in Borg values in acute dyspnoeic children. • Correlation between the change in EMG-measured diaphragmatic muscle activity and the change in FEV1 values in non-acute dyspnoeic children.

—

Countries

Netherlands

Outcome results